# Contineum Therapeutics Inc. (CTNM) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $16.70, market value $628 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Contineum Therapeutics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 2.6×**. The shares trade at 2.6× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -8.5%** (5-yr avg -14.7%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -23.0%**. Return on equity is negative because earnings are negative.
- **Return on assets: -15.3%**. Each dollar of assets produces -15.3% of profit.

## Growth
- **EPS growth (1 yr): 0.5%**. Earnings per share rose 0.5%.

## Financial health
- **Current ratio: 27.50** (quick 27.50). Current assets cover the next year's liabilities 27.50 times.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Contineum Therapeutics Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (7 analysts). 7 analysts cover Contineum Therapeutics Inc.; the consensus is strong_buy, with an average price target of $23.43 (+40% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 52.0%** (YTD 46.1%, 3-mo 45.3%). The shares are up 52.0% over twelve months including dividends.
- **From 52-week high: -6.1%** (94.2% above the low). Trading 6% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 55**. An RSI of 55 is neutral.
- **Beta (1 yr): 1.02** (volatility 67%). Beta of 1.02 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CTNM · Page: https://foliofundamentals.com/stocks/ctnm

Not investment advice.